Drugs / multivalent pneumococcal conjugate vaccine
multivalent pneumococcal conjugate vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05831124 Comparator | Apr 2023 → Jun 2024 | pneumococcal infection | Pfizer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | multivalent pneumococcal conjugate vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05831124 ↗ |
| Modality | Vaccine | “pneumococcal vaccine” NCT05831124 ↗ |
| Route | Intramuscular | “All participants will receive a single study vaccine shot in the upper arm muscle” NCT05831124 ↗ |